Publications

2016   2015    2014
 

2016

Abdallah IA, Hammell DC, Hassan HE, Stinchcomb AL.  Norelgestromin/ethinyl estradiol intravenous infusion formulation optimization, stability and compatibility testing:  A case study to overcome polysorbate 80 interference in chromatographic analysis.  J Pharm Biomed Anal.  June 5; 125:  145-153 (2016) PMID:  27018506 [Funding:  U01FD004955 Heat Effect on Generic Transdermal Drug Delivery Systems]

Abdallah IA, Hammell DC, Stinchcomb AL, Hassan HE.  A fully validated LC-MS/MS method for simultaneous determination of nicotine and its metabolite cotinine in human serum and its application to a pharmacokinetic study after using nicotine transdermal delivery systems with standard heat application in adult smokers.  J Chromatogr B Analyt Technol Biomed Life Sci.  May 1; 1020:  67-77 (2016) PMID:  27023159 [Funding:  U01FD004955 Heat Effect on Generic Transdermal Drug Delivery Systems]

Bhaveshkumar H. Kothari, Raafat M. Fahmy, Gregg Claycamp, Christine M. V. Moore, Sharmista Chatterjee and Stephen W. Hoag. Utilization of Statistical Model and Bayesian Approach to Establish Design Space for the Critical Process Parameters of the Coating Process at Different Scale Batches for the Manufacturing of Ciprofloxacin HCl Controlled Release Multiparticulate Beads. Submitted to AAPS PhamSciTech.

Bhaveshkumar H. Kothari, Raafat M. Fahmy, Gregg Claycamp, Christine M. V. Moore, Sharmista Chatterjee and Stephen W. Hoag, A Systematic Approach of Employing Quality by Design Principles: Risk Assessment and Design of Experiments to Demonstrate Process Understanding and Identify the Critical Process Parameters for Coating of the Ethylcellulose Pseudolatex Dispersion Using Non-Conventional Fluid Bed Process. AAPS PhamSciTech, In press (2016). DOI: 10.1208/s12249-016-0569-0.

Cage, K., Santos, L, Arumugam, S., and Vaughn-Cooke, M. Personal Health Record Design Preferences for High-Risk Demographic Patient Groups. (In review). 2016.

Cage, K., Santos, L., Morris, D., Arumugam, and Vaughn-Cooke, M. User-Centric Health Information Technology Design in High Risk Populations. (In review). 2016.

Claycamp HG, Kona R, Fahmy R, Hoag SW. Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets. AAPS PharmSciTech. 2016 Apr;17(2):233-44. doi: 10.1208/s12249-015-0349-2.

Dickinson PA, Kesisoglou F, Flangan T, Martinez MN, Mistry HB, Crison JR, Polli JE, Cruañes MT, Serajuddin AT, Müllertz A, Cook JA, Selen A. (2016): Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid. In press in J Pharm Sci.

Goodarzi N, Morgani AB, Abrahamsson B, Cristofoletti R, Groot DW, Langguth P, Mehta MU, Polli JE, Shah VP, Dressman JB: Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ribavirin. DOI: 10.1016/j.xphs.2016.01.017. April 2016. J. Pharm. Sci. 105:1362-1369.

Hudson A.J., Benjamen, J., Jardeleza T., Bergstrom C., Cronin W., Mendoza M., and Schultheis L. Comparative Analysis of Medical Use and Sports and Aviation Use Pulse Oximeters Reveals No Meaningful Difference. American Society of Anesthesiology Meeting, San Francisco, May 2016.

Kim, YW, Meyer, MT, Berkovich, A, Subramanian, S, Iliadis, AA, Bentley, WE, Ghodssi, R. A surface acoustic wave biofilm sensor integrated with a treatment method based on the bioelectric effect. February 2016. Sensors and Actuators. 238: 140-149, 2016. DOI: 10.1016/j.sna.2015.12.001

Kim, YW, Mosteller, MP, Subramanian, S, Meyer, MT, Bentley, WE, Ghodssi, R. An optical microfluidic platform for spatiotemporal biofilm treatment monitoring. Journal of Micromechanics and Microengineering. DOI 10.1088/0960-1317/26/1/015013. 2016.

Li Q, Yang H, Guo D, Zhang T, Polli JE, Zhou H, Shu Y. Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects. Drug Metab Dispos. 2016 Apr;44(4):489-94. doi: 10.1124/dmd.115.067223. Epub 2016 Jan 29. PMID: 26825640

Martinez M, Mistry B, Lukacova V, Polli J, Hoag S, Dowling T, Kona R, Fahmy R. (2016): Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin. DOI:10.1208/s12248-016-9913-2. AAPS J. 18:886-97. Epub 26 April 2016.

Quan, DN, Tsao, CY, Wu, HC., Bentley, WE. Quorum Sensing Desynchronization Leads to Bimodality and Patterned Behaviors. PLoS Computational Biology. 2016 April. 12(4). e1004781. DOI: 10.1371/journal.pcbi.1004781. 2016.  

Quan, DN, Tsao, CY, Wu, HC., Bentley, WE. Quorum Sensing Desynchronization Leads to Bimodality and Patterned Behaviors. PLoS Computational Biology. 12(4). e1004781. DOI: 10.1371/journal.pcbi.1004781. 2016. 

Raman S, Wu Y, Zheng J, and Polli JE: Analysis of Food-mediated Dissolution of a BCS Class II Drug using cryo-TEM. Submitted to Mol Pharmaceutics.

Raman S, Fahmy R, Martinez M, and Polli JE: Slower Surfactant-mediated Dissolution of Poorly Water-soluble Drugs in Biorelevant Media. In preparation for Eur J Pharm Sci.

Raman S. and Polli J.E. (2016): Prediction of Positive Food Effect: Bioavailability Enhancement of BCS Class II Drugs. DOI: 10.1016/j.ijpharm.2016.04.013. Int. J. Pharm. 506:110-115.

Rozner M.A., Schultheis L., and Schulman P.M. The Unstated Murphy's Law of the Operating Room: If Something Goes Wrong, Blame AnesthesiaA A Case Rep. 2016 Mar 15;6(6):139-41. doi: 10.1213/XAA.0000000000000262. PubMed PMID: 26954079.

Servinsky, MD, Terrell, JL, Tsao, CY, Wu, HC, Quan, DN, Zargar, A, Allen, PC, Byrd, CM, Sund, CJ, Bentley, WE. Directed Assembly of a Bacterial Quorum. ISME Journal. 10(1):158-169. DOI: 10.1038/ismej.2015.89. 2016.   

Sumbramanian, S., Gerasopooulos, K., Guo, M., Sintim, H.O., Bentley, W.E., Ghodssi R., Investigation of the Combination of Autoinducer-2 Analogs and Electric Fields as a High-Efficacy Bacterial Biofilm Treatment. Biomicrofluidics. (in press).

Subramanian, S., Gerasopoulos, K., Guo, M., Sintim, H.O., Bentley, W.E., Ghoddsi, R., Autoinducer-2 Analogs and Electric Fields - An Antibiotic-Free Bacterial Biofilm Combination Treatment. Biomedical Microdevices. (in press).

Tschirhart, T, Zhou, XYY, Ueda, H, Tsao, CY, Kim, E, Payne, GF, Bentley, WE. Electrochemical Measurement of the beta-Galactosidase Reporter from Live Cells: A Comparison to the Miller Assay. ACS Synthetic Biology. 5(1):28-35. DOI: 10.1021/acssynbio5b00073. 2016. 

Vaithianathan S and Polli JE: Impact of In Vitro Dissolution Volume on the Performance of Solid Oral Dosage Forms of Three Anti-Epileptic Drugs. Submitted to AAPS J.

Vaithianathan S., Haidar S.H., Zhang X., Jiang W., Avon C., Dowling T.C., Shao C., Kane M., Hoag S.W., Flasar M.H., Ting T.Y., and Polli J.E. On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs. J Pharm Sci. 2016 Apr;105(4):1355-7. doi: 10.1016/j.xphs.2016.02.028.

Vaithianathan S., Haidar S.H., Zhang X., Jiang W., Avon C., Dowling T.C., Shao C., Kane M., Hoag S.W., Flasar M.H., Ting T.Y., and Polli J.E. Effect of Common Excipients on the Oral Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and AcyclovirJ Pharm Sci. 2016 Feb;105(2):996-1005. doi: 10.1002/jps.24643. Epub 2016 Jan 12.

Vaithianathan, S., Haidar, S.H., Zhang, X., Jiang, W., Avon, C., Dowling, T.C., Kane, M.A., Hoag, S.W., Flasar, M.H., Ting, T.Y., and Polli, J.E. (2016): Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir. DOI: 10.1002/jps.24643. J. Pharm. Sci. 105:996-1005.

Vaithianathan, S., Haidar, S.H., Zhang, X., Jiang, W., Avon, C., Dowling, T.C., Kane, M.A., Hoag, S.W., Flasar, M.H., Ting, T.Y., and Polli, J.E. (2016): Reply to “On the Effect of Common Excipients on the Oral Absorption of Class 3 Drugs”. DOI: 10.1016/j.xphs.2016.02.028. J. Pharm. Sci. 105:1355-1357.

Vaithianathan S., Ting T.Y., Jiang W., and Polli J.E. (2016): Release of levetiracetam from extended-release tablets that appear intact in patient stool DOI: 10.1016/j.seizure.2016.05.011. In press in Seizure-Eur. J. Epilep.

Wang, MO, Vorwald, CE, Dreher, ML, Mott, EJ, Cheng, MH, Cinar, A, Mehdizadeh, H, Somo, S, Dean, D, Brey, EM, Fisher, JP. Evaluating 3D-Printed Biomaterials as Scaffolds for Vascularized Bone Tissue Engineering. Advanced Materials. 27(1):138-144. 2026. DOI: 10.1002/adma.201403943.

Yu LX, Akseli, I, Allen B, Amidon G, Gooen Bizjak T, Boam A, Caulk M, Doleski D, Famulare J, Fisher AC, Furness S, Hasselbalch B, Havel H, Hoag SW, Iser R, Johnson BD, Ju R, Katz P, Lacana E, Lee SL, Lostritto R, McNally G, Mehta M, Mohan G, Nasr M, Nosal R, Oates M, O’Connor T, Polli J, Raju1 GK, Ramanadham M, Randazzo G, Rosencrance S, Schwendeman A, Selen A, Seo P, Shah V, Sood R, Thien MP, Tong T, Trout BL, Tyner K, Vaithiyalingam S, VanTrieste M, Walsh F, Wesdyk R, Woodcock J, Wu G, Wu L, Yu L, Zezza D.: Advancing Product Quality: A Summary of the Second FDA/PQRI Conference. March 2016. DOI: 10.1208/s12248-016-9874-5. AAPS J. 18:528-543.

 


2015

Albrecht J.S., Khokhar B., Pradel F., Campbell M., Palmer J., Harris I., and Palumbo F. Perceptions of patient provider agreements. J Pharm Health Serv Res. 2015. Sept;6(3):139-144.doi:10.1111/jphs.12099.

Cage, K., Santos, L, Arumugam, S., and Vaughn-Cooke, M. Personal Health Record Design Preferences for High-Risk Demographic Patient Groups. To be submitted to American Journal of Public Health, July 2015. 

Cage, K., Santos, L., Morris, D., Arumugam, and Vaughn-Cooke, M. User-Centric Health Information Technology Design in High Risk Populations. To be submitted to Human Factors, June 2015. 

Cristofoletti, R, Shah, VP, Langguth, P, Polli, JE, Mehta, M, Abrahamsson, B, Dressman, JB, Quiroge, P. (2015): Meeting Report: International Workshop on Implementation of Biowaivers Based on the Biopharmaceutics Classification System (BCS). Diss Technol. 22:77-81.

Dong Z., Ekins S., Polli J.E. (2015): Quantitative NTCP Pharmacophore and Lack of Association between DILI and NTCP Inhibition. DOI:10.1016/j.ejps.2014.09.005. Eur. J. Pharm. Sci. 66:1-9. 

Dong Z., Ekins S., and Polli J.E. (2015): A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide. DOI:10.1016/j.ijpharm.2014.11.022. Int. J. Pharm. 478:88-95.

Dong Z., Li Q., Shu Y., Polli J.E. (2015): Synthesis and Evaluation of Bile acid-ribavirin Conjugates as Prodrugs to Target the Liver. DOI: 10.1002/jps.24375. J. Pharm Sci. 104:2864-76.   

Feng, Y., Taraban, M.B., and Yu Y.B. (2015). Water proton NMR - a sensitive probe for solute  association.  Chem. Comm. 51, 6804-6807.  PMCID: exempt.

Feng Y, Taraban MB, Yu YB. Water proton NMR-a sensitive probe for solute association. Chem Commun (Camb). 2015 Apr 21;51(31):6804-7. doi: 10.1039/c5cc00741k.

Gajendran J, Krämer J, Shah VP, Langguth P, Polli J, Mehta M, Groot DW, Cristofoletti R, Abrahamsson B, Dressman JB: Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Nifedipine. October 2015. DOI: 10.1002/jps.24560. J. Pharm Sci. 104:3289-98.

Ghassemi P., Wang J., Melchiorri A.J., Ramella-Roman J.C., Mathews S.A., Coburn J.C., Sorg B.S., Chen Y., and Pfefer T.J. 3D Printed Biomimetic Vascular Phantoms for Assessment of Hyperspectral Imaging and Diffuse Reflectance Systems. J Biomed Opt. 2015;20(12):121312. doi: 10.1117/1.JBO.20.12.121312.

Harris Howland, Raafat M. Fahmy and Stephen W. Hoag, Analysis of Curing of a Sustained Release Coating Formulation by Application of NIR Spectroscopy to Monitor Changes Associated with Glyceryl Monostearate, Drug Dev. Ind. Pharm., 41(8):1263-1273 (2015). DOI: 10.3109/03639045.2014.947505.

Kona R, Fahmy RM, Claycamp G, Polli JE, Martinez M, and Hoag SW. (2015): Quality-by-Design III: Application of Near-Infrared Spectroscopy to Monitor Roller Compaction In-process and Product Quality Attributes of Immediate Release Tablets. DOI: 10.1208/s12249-014-0180-1. AAPS PharmSciTech.

Meyer, MT, Subramanian, S, Kim, YW, Ben-Yoav, H, Gnerlich, M, Gerasopoulos, K, Bentley, WE, Ghodssi, R. Multi-depth valved microfluidics for biofilm segmentation. Journal of Micromechanics and Microengineering. 10.1088/0960-1317/25/9/095003. 2015.

Moolchandani Vikas , Larry L. Augsburger, Abhay Gupta, Mansoor Khan, John Langridge, and Stephen W. Hoag, To investigate the influence of machine operating variables on formulations derived from lactose types in capsule filling: Part 2, Drug Dev. Ind. Pharm. Early-online (2015). DOI: 10.3109/03639045.2015.1062511

Raufman JP, Dawson PA, Rao A, Drachenberg CB, Heath J, Shang AC, Hu S, Zhan M, Polli JE, Cheng K. (2015): Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. DOI: 10.1093/carcin/bgv107. Carcinogenesis 36:1193-200.

Schultheis L. Academic Involvement: A Treatment for Regulatory Fatigue. Anesth Analg. 2015 Aug;121(2):255-8. doi: 10.1213/ANE.0000000000000816. PubMed PMID: 26197363.

Taraban, M.B., Truong, H.C., Feng, Y., Jouravleva, E.V.,  Anisimov, M.A.,  and Yu, Y.B. (2015). Water proton NMR for in situ detection of insulin aggregates.  J. Pharm. Sci., Dec;104(12):4132-41. doi:10.1002/jps.24633. Epub 2015 Sep 7.

Ting T.Y., Jiang W., Lionberger R., Wong J., Jones J.W., Kane M.A., Krumholz A., Temple R., and Polli J.E. Generic Lamotrigine Versus Brand-Name Lamictal Bioequivalence in Patients With Epilepsy: A Field Test of the FDA Bioequivalence Standard. Epilepsia 2015;56(9):1415–1424. doi:10.1111/epi.13095.

Vaithianathan S, Raman, S, Jiang W, Ting TY, Kane MA, and Polli JE. (2015): Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets. DOI: 10.1021/acs.molpharmaceut.5b00154. Mol Pharmaceutics 12: 2436−2443.

Vivek S. Dave, Raafat M. Fahmy and Stephen W. Hoag, Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature, Drug Dev. Ind. Pharm., 41(6):898-905 (2015). DOI: 10.3109/03639045.2014.911883.

Yang H, Shu Y. Cadmium Transporters in the Kidney and Cadmium-Induced Nephrotoxicity. Int. J. Mol. Sci. 2015, 16, 1484-1494; doi:10.3390/ijms16011484.

Wang M.O., Piard C., Melchiorri A.J., Dreher M.L., and Fisher J.P. Evaluating Changes in Structure and Cytotoxicity During In Vitro Degradation of 3D Printed Scaffolds. Tissue Engineering, Part A. 21: 1642-1653 (2015).

Wang M.O.,  Vorwald C.E., Dreher M.L., Mott E.J., Cheng M.H., Cinar A., Mehdizadeh H., Somo S., Dean D., Brey E.M., and Fisher J.P. Evaluating 3D Printed Biomaterials as Scaffolds for Vascularized Bone Tissue Engineering. Advanced Materials. 27: 138-144 (2015).

Wong, J.M, Jones, J.W., Jiang, W., Polli, J.E., and Kane, M.A. (2015): Quantification of lamotrigine in patient plasma utilizing a fast liquid chromatography-tandem mass spectrometry method with backflush technology. DOI: 10.1097/FTD.0000000000000123. Ther. Drug Monit. 37:188-197.

 

2014

Bowen L., Carter-Pokras O.,  and Kohrt B.: Health Literacy and Cultural Competency of FDA Consumer Materials. Annals of Epidemiology 2014, 24(9):668.

Dean D., Mott E., Luo X., Busso M., Wang M.O., Vorwald C., Siblani A., and Fisher J.P. Multiple Initiators and Dyes for Continuous Digital Light Processing (cDLP) Additive Manufacture of Resorbable Bone Tissue Engineering ScaffoldsVirtual and Phys Prototyp 2014, 9: 3-9.

Dong Z., Ekins S., and Polli J.E.: Quantitative NTCP Pharmacophore and Lack of Association between DILI and NTCP Inhibition. DOI:10.1016/j.ejps.2014.09.005. Eur. J. Pharm. Sci. 66:1-9. 

Dong Z., Ekins S., and Polli J.E.: A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide. DOI:10.1016/j.ijpharm.2014.11.022. Int. J. Pharm. 478:88-95.

Dong, Z., Ekins, S., and Polli, J.E.: Structure Activity Relationship for FDA Approved Drugs as Inhibitors of the Human Sodium Taurocholate Co-transporting Polypeptide (NTCP). DOI: 10.1021/mp300453k. Mol. Pharmaceutics. 10: 1008-1019.

Gandhi, S., Rodriguez, W., Khan, M., and Polli, J.E. (2014): Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs. DOI: 10.1208/s12249-014-0084-0. June 2014. AAPS PharmSciTech. 15:601-611.

Garzel B., Yang H., Lynch C., Zhang L., Huang S., Polli J., and Wang H. The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicityDrug Metab Dispos 2014, 42(3):318-322.

Gordonov T., Kim E., Cheng Y., Ben-Yoav H., Ghodssi R., Rubloff G., Yin J.J., Payne G.F., and Bentley W.E. Electronic modulation of biochemical signal generation. Nat Nanotechnol. 2014 Aug;9(8):605-10. doi: 10.1038/nnano.2014.151. Epub 2014 Jul 27.

Li, M., Tan J.,  Tarlov M., and Zachariah, M.R.. Absolute Quantitative Method for Protein Concentration.  November 2014. Analytical Chemistry, 86, 12130 (2014) DOI: 10.1021/ac5030123

Li Q., and Shu Y. Role of solute carriers in response to anticancer drugsMolecular and Cellular Therapies 2014, 2(15).

Li Q., and Shu Y. Pharmacological modulation of cytotoxicity and cellular uptake of anti-cancer drugs by PDE5 inhibitors in lung cancer cellsPharm Res 2014, 31(1):86-96.

Moolchandani Vikas , Larry L. Augsburger, Abhay Gupta, Mansoor Khan, John Langridge, and Stephen W. Hoag, Characterization and selection of suitable grades of lactose as functional fillers for capsule filling: part 1, Drug Dev. Ind. Pharm. Early-online (2014). DOI: 10.3109/03639045.2014.957703

Palmer J.B., Albrecht J.S., Park Y., Dutcher S., Rattinger G.B., Simoni-Wastila L., Walker L.D., and Zuckerman I.H. Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of Medicare beneficiaries from 2007 to 2008. Drugs and Aging Published online 10 December 2014. DOI 0.1007/s40266-014-0227.

Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, Martinez MN, Lennernäs H, Wigal TL, Swinney DC, Polli JE, Serajuddin AT, Cook JA, Dressman JB. 2014: The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. September 2014. DOI: 10.1002/jps.24162. J. Pharm Sci. 103:3377-97.

Terrell, JL, Wu, HC, Tsao, CY, Barber, NB, Servinsky, MD, Payne, GF, Bentley, WE. Nano-guided cell networks as conveyors of molecular communication. Nature Communications. 6:8500. DOI: 10.1038/ncomms9500. 2015.

Vivian D., Cheng K., Khurana S., Xu S., Kriel E.H., Dawson P.A., Raufman J.P., and Polli J.E. In vivo performance of a novel fluorinated Magnetic Resonance Imaging agent for functional analysis of bile acid transport. Mol Pharm 2014, 11(5):1575-1582.

Vivian D., Cheng K., Khurana S., Xu S., Dawson P.A., Raufman J.P., and Polli J.E. (2014): Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using Fluorine Magnetic Resonance Imaging (MRI). DOI: 10.1002/jps.24131. J.PharmSc.103:3782-2792.

Vivian D. and Polli J.E. (2014): Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver. DOI:10.1016/j.ijpharm.2014.09.014. Int. J. Pharm. 475:597-604.

Vivian D., and Polli J.E. Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter systemEur J Pharm Sci 2014, 64:44-52. 

Wallace J., Wang M.O., Thompson P., Busso M., Belle V., Mammoser N., Kim K., Fisher J.P., Siblani A., Xu Y., Welter J.F., Lennon D.P., Sun J., Caplan A.L., and Dean D.: Validating continuous digital light processing (cDLP) additive manufacturing accuracy and tissue engineering utility of a dye-initiator packageBiofabrication 2014, 6(1):015003.

Wang J., Coburn J., Woolsey N., Liang C.P., Ramella-Roman J., Chen Y., Pfefer J.: Quantitative assessment of biophotonic imaging system performance with phantoms fabricated by rapid prototypingProceedings of SPIE 2014, 89360M. doi: 10.1117/12.2044089.

Wang J., Coburn J., Liang C.P., Woolsey N., Ramella-Roman J.C., Chen Y., Pfefer T.J. Three-dimensional printing of tissue phantoms for biophotonic imagingOpt Lett 2014, 39(10):3010-3013.

Wang, MO, Piard, C, Dreher, ML, Melchiorri, A, Fisher, JP. Degradation of 3D printed poly(propylene fumarate) scaffolds. Journal of Tissue Engineering and Regenerative Medicine. 8:90-91. 2014 (Meeting Abstract).

Wang, MO, Piard, C, Dreher, ML, Melchiorri, A, Fisher, JP. Degradation of 3D printed poly(propylene fumarate) scaffolds. Journal of Tissue Engineering and Regenerative Medicine. 8:443-443. 2014. (Meeting Abstract)